128.92
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$128.10
Aprire:
$128.44
Volume 24 ore:
194.66K
Relative Volume:
0.44
Capitalizzazione di mercato:
$8.49B
Reddito:
$3.55B
Utile/perdita netta:
$370.24M
Rapporto P/E:
23.53
EPS:
5.48
Flusso di cassa netto:
$355.96M
1 W Prestazione:
-1.30%
1M Prestazione:
-4.66%
6M Prestazione:
-11.10%
1 anno Prestazione:
-22.36%
Aptargroup Inc Stock (ATR) Company Profile
Nome
Aptargroup Inc
Settore
Industria
Telefono
(815) 477-0424
Indirizzo
265 EXCHANGE DRIVE, CRYSTAL LAKE, IL
Confronta ATR con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ATR
Aptargroup Inc
|
128.90 | 8.55B | 3.55B | 370.24M | 355.96M | 5.48 |
![]()
ISRG
Intuitive Surgical Inc
|
434.85 | 156.44B | 9.15B | 2.63B | 1.99B | 7.1661 |
![]()
BDX
Becton Dickinson Co
|
183.42 | 53.99B | 21.39B | 1.61B | 2.55B | 5.5609 |
![]()
RMD
Resmed Inc
|
270.14 | 39.41B | 5.15B | 1.40B | 1.65B | 9.5082 |
![]()
ALC
Alcon Inc
|
75.16 | 36.63B | 10.03B | 1.07B | 1.39B | 2.1549 |
![]()
WST
West Pharmaceutical Services Inc
|
265.83 | 18.78B | 2.96B | 487.70M | 344.00M | 6.6758 |
Aptargroup Inc Stock (ATR) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-09-04 | Iniziato | KeyBanc Capital Markets | Overweight |
2025-01-07 | Iniziato | Raymond James | Outperform |
2025-01-06 | Downgrade | BofA Securities | Buy → Neutral |
2024-10-14 | Aggiornamento | Jefferies | Hold → Buy |
2024-04-29 | Aggiornamento | William Blair | Mkt Perform → Outperform |
2024-01-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2021-08-02 | Downgrade | William Blair | Outperform → Mkt Perform |
2021-04-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
2020-10-14 | Iniziato | Seaport Global Securities | Neutral |
2020-04-27 | Aggiornamento | BofA/Merrill | Neutral → Buy |
2020-03-25 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
2020-03-04 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
2020-02-26 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2019-07-08 | Iniziato | Morgan Stanley | Overweight |
2019-04-05 | Reiterato | BofA/Merrill | Underperform |
2019-02-27 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2018-05-18 | Iniziato | Jefferies | Hold |
2016-12-07 | Downgrade | BofA/Merrill | Buy → Underperform |
2016-10-13 | Iniziato | Jefferies | Hold |
2016-01-05 | Downgrade | Robert W. Baird | Outperform → Neutral |
2015-11-02 | Aggiornamento | Deutsche Bank | Hold → Buy |
2015-09-15 | Aggiornamento | BofA/Merrill | Neutral → Buy |
2015-05-01 | Aggiornamento | BofA/Merrill | Underperform → Neutral |
2013-02-19 | Reiterato | Deutsche Bank | Hold |
2013-01-08 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2012-07-10 | Downgrade | KeyBanc Capital Mkts | Buy → Hold |
2012-04-11 | Iniziato | KeyBanc Capital Mkts | Buy |
2011-06-13 | Aggiornamento | KeyBanc Capital Mkts | Hold → Buy |
Mostra tutto
Aptargroup Inc Borsa (ATR) Ultime notizie
No. 72 of 400: Aptar named to Forbes' World's Top Companies for Women 2025 — 5th consecutive year - Stock Titan
Aptar Named Among Top 100 of the ‘World’s Top Companies for Women 2025’ by Forbes - Eagle-Tribune
Can swing trading help recover from AptarGroup Inc. lossesVolume Spike & Reliable Entry Point Alerts - newser.com
AptarGroup stock hits 52-week low at $128.85 By Investing.com - Investing.com Canada
Key metrics from AptarGroup Inc.’s quarterly dataQuarterly Portfolio Summary & Reliable Intraday Trade Plans - newser.com
AptarGroup stock hits 52-week low at $128.85 - Investing.com India
Statistical indicators supporting AptarGroup Inc.’s strengthJuly 2025 Drop Watch & Long Hold Capital Preservation Tips - newser.com
Is AptarGroup Inc. stock supported by strong cash flowsWeekly Market Outlook & Intraday High Probability Setup Alerts - newser.com
Candlestick signals on AptarGroup Inc. stock todayTrade Exit Report & AI Powered Market Trend Analysis - newser.com
AptarGroup Q2 2025 slides: 18% EPS growth as all segments expand margins - Investing.com India
Earnings call transcript: AptarGroup’s Q2 2025 shows strong EPS growth - Investing.com India
Earnings call transcript: AptarGroup’s Q2 2025 shows strong EPS growth By Investing.com - Investing.com UK
Tick level data insight on AptarGroup Inc. volatility2025 Trade Ideas & Technical Buy Zone Confirmations - newser.com
Will AptarGroup Inc. benefit from macro trendsMarket Trend Review & Weekly Momentum Stock Picks - newser.com
How AptarGroup Inc. stock performs in interest rate cyclesMarket Activity Recap & Verified Swing Trading Watchlists - newser.com
AptarGroup, Inc. (ATR) Investor Outlook: Strong Buy Ratings And 34% Upside Potential - DirectorsTalk Interviews
Will AptarGroup Inc. stock recover faster than marketJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com
Will AptarGroup Inc. (AGT) stock see insider accumulationIndex Update & AI Driven Stock Movement Reports - newser.com
How high can AptarGroup Inc. stock go2025 Analyst Calls & Capital Protection Trading Alerts - newser.com
Should AptarGroup’s (ATR) Nasus Pharma Partnership Shift Investor Expectations for Pharma Segment Innovation? - simplywall.st
Is AptarGroup Inc. (AGT) stock worth buying before Fed action2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - newser.com
Will AptarGroup Inc. stock rise with strong economyProfit Target & Community Consensus Trade Alerts - newser.com
Technical analysis overview for AptarGroup Inc. stockMarket Growth Report & Pattern Based Trade Signal System - newser.com
What moving averages say about AptarGroup Inc.2025 Performance Recap & Weekly High Momentum Picks - newser.com
Will breakout in AptarGroup Inc. lead to full recoveryMarket Performance Report & AI Forecast for Swing Trade Picks - newser.com
Can AptarGroup Inc. stock deliver sustainable ROEJuly 2025 Earnings & Daily Stock Trend Reports - newser.com
Nasus Pharma partners with Aptar for intranasal epinephrine development By Investing.com - Investing.com South Africa
Nasus Pharma Expands Collaboration with Aptar for Intranasal Epinephrine Program - TipRanks
Nasus Pharma Ltd. Extends Collaboration with AptarGroup, Inc. and AptarGroup, Inc - MarketScreener
AptarGroup (ATR) Partners with Nasus Pharma for NS002 Developmen - GuruFocus
Nasus Pharma partners with Aptar for intranasal epinephrine development - Investing.com
AptarGroup stock hits 52-week low at 130.24 USD By Investing.com - Investing.com Canada
AptarGroup stock hits 52-week low at 130.24 USD - Investing.com
Aptar Beauty and Clarins Launch the New Reloadable Total Eye Lift - Aptar
AptarGroup : CDP Corporate Questionnaire (2025 0916 CDP 2025) - MarketScreener
Market reaction to AptarGroup Inc.’s recent newsEarnings Miss & Community Driven Trade Alerts - newser.com
AptarGroup Inc. stock volume spike explainedRate Cut & High Return Trade Opportunity Guides - newser.com
AptarGroup, Inc. (ATR) Stock Analysis: Exploring A Potential 32.76% Upside For Investors - DirectorsTalk Interviews
How rising interest rates impact AptarGroup Inc. stockJuly 2025 Rallies & Comprehensive Market Scan Reports - newser.com
Aptargroup Inc Azioni (ATR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):